期刊文献+
共找到190篇文章
< 1 2 10 >
每页显示 20 50 100
乳腺癌保乳术后采用APBI-IMRT的效果
1
作者 谌海波 朱洪雨 孙黎清 《中外医学研究》 2024年第4期119-122,共4页
目的:探讨乳腺癌保乳术后采用加速部分乳腺调强放疗(accelerated partial breast irradiation with intensitymodulated radiation therapy,APBI-IMRT)的效果。方法:选择2018年6月—2022年9月南京大学医学院附属苏州医院收治的82例行乳... 目的:探讨乳腺癌保乳术后采用加速部分乳腺调强放疗(accelerated partial breast irradiation with intensitymodulated radiation therapy,APBI-IMRT)的效果。方法:选择2018年6月—2022年9月南京大学医学院附属苏州医院收治的82例行乳腺癌保乳术患者作为研究对象,以随机数表法将患者分为对照组与研究组,各41例。对照组应用常规放疗,研究组应用APBI-IMRT,比较两组肿瘤标志物、危险器官剂量、心功能指标。结果:治疗前,两组肿瘤标志物、心功能指标比较,差异无统计学意义(P>0.05);治疗后,两组癌胚抗原(carcinoembryonic antigen,CEA)、β_(2)-微球蛋白(β_(2)-Microglobulin,β_(2)-MG)、细胞角蛋白19片段(cytokeratin 19 fragment,CYFRA21-1)、甲胎蛋白(alpha fetoprotein,AFP)水平、左房收缩末期内径(left atrial end-systolic diameter,LADs)、左室舒张末期内径(left ventricular end diastolic dimension,LVDD)、射血分数(ejection fraction,EF)、左心室短轴缩短率(fraction shortening,FS)较治疗前降低,且研究组肿瘤标志物低于对照组,但心功能指标高于对照组,差异有统计学意义(P<0.05)。研究组危险器官剂量低于对照组,差异有统计学意义(P<0.05)。结论:APBI-IMRT在乳腺癌保乳术后应用可增强治疗效果,降低对心肺功能的损伤。 展开更多
关键词 乳腺癌保乳术 肿瘤标志物 加速部分乳腺调强放疗 心功能 乳腺癌
下载PDF
Clinical study on concurrent and sequential therapy of intensity modulated radiation therapy (IMRT) combined with NP regimen chemotherapy in the treatment of middle and advanced non-small cell lung cancer
2
作者 Xiaodong Jiang Da'an Song Weiming Zhang Jin Wu 《The Chinese-German Journal of Clinical Oncology》 CAS 2007年第1期2-4,共3页
Objective: To evaluate the clinical effects of concurrent and sequential therapy for middle and advanced stage non-small cell lung cancer (NSCLC) useing IMRT combined with NP regimen chemotherapy. Methods: Eighty pati... Objective: To evaluate the clinical effects of concurrent and sequential therapy for middle and advanced stage non-small cell lung cancer (NSCLC) useing IMRT combined with NP regimen chemotherapy. Methods: Eighty patients with middle and advanced stage NSCLC were randomized into two groups. Forty patients were underwent sequential therapy and other 40 patients were underwent concurrent therapy. IMRT was used in radiotherapy and NP regimen of vinorelbine+cispatin (NP) was used in chemotherapy. Results: (1) The overall response (CR+PR) rate was 75% in concurrent group and 45% in sequential group (P<0.05); (2) The treatment courses were 84 days and 140 days for concurrent group and sequential group respectively (P<0.05); (3) One-year survival rate in concurrent group was 72.4% and 52.3% in sequential group respectively; (4) The toxic effects can be tolerable by all of patients. Conclusion: The concurrent chemo-radiotherapy has better overall re- sponse, one-year survival rate and shorter treatment course than the sequential chemo-radiotherapy, so it is a better method for the treatment of middle and advanced stage NSCLC, but the long term survival rate will be studied. 展开更多
关键词 中晚期 非小细胞肺癌 适形调强放疗 NP方案化疗 同期联合治疗 序贯治疗 临床研究
下载PDF
Local definitive intensity-modulated radiation therapy recommended for patients initially diagnosed with nasopharyngeal carcinoma with distant metastasis after an effective systemic chemotherapy
3
作者 Lei Zhou Dongbo Liu 《Oncology and Translational Medicine》 2018年第6期234-237,共4页
Objective The aim of the study was to propose a hypothesis that local definitive intensity-modulated radiation therapy(IMRT) should be recommended for initially diagnosed metastatic nasopharyngeal carcinoma(NPC) and d... Objective The aim of the study was to propose a hypothesis that local definitive intensity-modulated radiation therapy(IMRT) should be recommended for initially diagnosed metastatic nasopharyngeal carcinoma(NPC) and demonstrate its feasibility.Methods Recently published papers on local definitive radiotherapy for initially diagnosed metastatic NPC were reviewed to propose a hypothesis.Results Several studies revealed the survival benefits of adding local definitive radiotherapy to the systemic chemotherapy in patients initially diagnosed with metastatic NPC.Conclusion We suggested that local definitive IMRT should be recommended in patients initially diagnosed with NPC with distant metastasis after an effective systemic chemotherapy, which may possibly prolong their survival time and potentially treat the disease. 展开更多
关键词 NASOPHARYNGEAL carcinoma(NPC) METASTASIS INTENSITY-MODULATED radiation therapy(imrt)
下载PDF
Verification of Dosimetric and Positional Accuracy of Dynamic Tumor Tracking Intensity Modulated Radiation Therapy
4
作者 Masaki Sueoka Akira Sawada +6 位作者 Hiroaki Tanabe Yuki Okada Sho Taniuchi Noboru Okuuchi Masao Tanooka Masaki Kokubo Koichiro Yamakado 《International Journal of Medical Physics, Clinical Engineering and Radiation Oncology》 2019年第4期211-224,共14页
Purpose: We performed both, dosimetric and positional accuracy verification of dynamic tumor tracking (DTT) intensity modulated radiation therapy (IMRT), with the Vero4DRT system using a moving phantom (QUASAR respira... Purpose: We performed both, dosimetric and positional accuracy verification of dynamic tumor tracking (DTT) intensity modulated radiation therapy (IMRT), with the Vero4DRT system using a moving phantom (QUASAR respiratory motion platform;QUASAR phantom) and system log files. Methods: The QUASAR phantom was placed on a treatment couch. Measurement of the point dose and dose distribution was performed for conventional IMRT, with the QUASAR phantom static and moving;for DTT IMRT, this was performed with the phantom moving for pyramid shaped, prostate, paranasal sinus, and pancreas targets. The QUASAR phantom was driven by a sinusoidal signal in the superior-inferior direction. Furthermore, predicted positional errors induced by the Vero4DRT system and mechanical positional errors of the gimbal head, were calculated using the system log files. Results and Conclusion: For DTT IMRT, the dose at the evaluation point was within 3% compared with the verification plan, and the dose distribution in the passing rates of γ was 97.9%, with the criteria of 3% dose and 3 mm distance to agreement. The position error calculated from the log files was within 2 mm, suggesting the feasibility of employing DTT IMRT with high accuracy using the Vero4DRT system. 展开更多
关键词 DYNAMIC Tumor Tracking (DTT) Intensity Modulated radiation therapy (imrt) Point DOSE VERIFICATION DOSE Distribution VERIFICATION Log FILE Analysis
下载PDF
Intraoperative radiation therapy deserves to be made more readily available to patients
5
作者 Mohammed Keshtgar Norman R.Williams 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2016年第4期461-462,共2页
Whole breast external beam radiotherapy is an effective adjuvant treatment for early breast cancer, and was a key factor in the move from mastectomy to breast-conserving surgery for women with low-risk disease. The lo... Whole breast external beam radiotherapy is an effective adjuvant treatment for early breast cancer, and was a key factor in the move from mastectomy to breast-conserving surgery for women with low-risk disease. The logical development from partial surgical removal of the breast is partial breast radiotherapy. Several methods of delivery have been investigated, but as yet none has been widely accepted. 展开更多
关键词 MORE Intraoperative radiation therapy deserves to be made more readily available to patients imrt
下载PDF
Evaluating the influence of 6 MV and 15 MV photon beams on prostate intensity-modulated radiation therapy plans
6
作者 Reham A.El Gendy Ehab M.Attalla +1 位作者 Yasser M.Elkerm Ali Alfarrash 《Oncology and Translational Medicine》 2016年第1期26-33,共8页
Objective We aimed to determine the effects of low- and high-energy intensity-modulated radiation therapy(IMRT) photon beams on the target volume planning and on the critical organs in the case of prostate cancer. Met... Objective We aimed to determine the effects of low- and high-energy intensity-modulated radiation therapy(IMRT) photon beams on the target volume planning and on the critical organs in the case of prostate cancer. Methods Thirty plans were generated by using either 6 MV or 15 MV beams separately, and a combination of both 6 and 15 MV beams. All plans were generated by using suitable planning objectives and dose constraints, which were identical across the plans, except the beam energy. The plans were analyzed in terms of their target coverage, conformity, and homogeneity, regardless of the beam energy. Results The mean percentage values of V_(70 Gy) for the rectal wall for the plans with 6 MV, 15 MV, and mixedenergy beams were 16.9%, 17.8%, and 16.4%, respectively, while the mean percentage values of V_(40 Gy) were 53.6%, 52.3%, and 50.4%. The mean dose values to the femoral heads for the 6 MV, 15 MV, and mixed-energy plans were 30.1 Gy, 25.5 Gy, and 25.4 Gy, respectively. The mean integral dose for the 6 MV plans was 10% larger than those for the 15 MV and mixed-energy plans. Conclusion These preliminary results suggest that mixed-energy IMRT plans may be advantageous with respect to the dosimetric characteristics of low- and high-energy beams. Although the reduction of dose to the organs at risk may not be clinically relevant, in this study, IMRT plans using mixed-energy beams exhibited better OAR sparing and overall higher plan quality for deep-seated tumors. 展开更多
关键词 放射治疗 前列腺癌 光子束 剂量学特性 评价 能源计划 高能量 高能粒子束
下载PDF
基于美国医学物理学家协会TG119报告的TaiChi加速器质量控制体系建立研究
7
作者 庞廷田 王涛 +7 位作者 雷琪琪 杨波 汪之群 张杰 陈胤竹 李世豪 昝鹏 邱杰 《中国医学装备》 2024年第6期1-5,11,共6页
目的:依据美国医学物理学家协会(AAPM)TG119号报告测试方法和项目对TaiChi加速器在RayStation治疗计划系统(简称RayStation系统)中的建模数据模型进行测试评估。方法:在治疗计划系统中按AAPM TG119号报告要求设计模拟多靶区、前列腺靶... 目的:依据美国医学物理学家协会(AAPM)TG119号报告测试方法和项目对TaiChi加速器在RayStation治疗计划系统(简称RayStation系统)中的建模数据模型进行测试评估。方法:在治疗计划系统中按AAPM TG119号报告要求设计模拟多靶区、前列腺靶区、头颈靶区、容易型C形靶区计划和困难型C形靶区计划等不同临床情况测试病例的调强放射治疗(IMRT)和容积旋转调强放射治疗(VMAT)计划,测量两种计划中点剂量和面积量偏差,并将测试结果与AAPM TG119报告中推荐的标准进行对比分析。使用IBA CC13电离室和ArcCHECK矩阵电离室分别对点剂量和面剂量进行验证,评估标准为3%/3mm的γ通过率。采用置信度评判测量剂量与计算剂量的一致性。结果:测试病例计划剂量目标、点剂量偏差及面剂量分布准确性均满足报告要求:测试病例IMRT和VMAT计划的靶区高剂量点平均剂量偏差分别为(0.39±1.02)%和(1.27±0.64)%,置信度分别为2.39%和2.52%。IMRT和VMAT计划的危及器官(OAR)低剂量点平均剂量偏差分别为(0.53±1.73)%和(0.88±1.11)%,置信度分别为3.92%和3.06%。IMRT和VMAT计划3%/3mm标准下的平均γ通过率分别为(99.52±0.366)%和(99.86±0.136)%,置信度分别为1.196%和0.406%。结论:TaiChi加速器性能和Raystation系统6MV FFF模型拟合精度满足AAPM TG119号报告标准,依据此测试结果建立后续设备和患者质控的标准,并为后续加速器性能的改进提供了参考。 展开更多
关键词 美国医学物理家协会(AAPM)TG119报告 加速器 调强放射治疗(imrt) 容积旋转调强放射治疗(VMAT)
下载PDF
重叠体积直方图描述子的计算方法和其在鼻咽癌IMRT计划检索中的应用 被引量:5
8
作者 王东东 周正东 +3 位作者 宋威 李兵 沈君姝 朱锡旭 《中国生物医学工程学报》 CAS CSCD 北大核心 2014年第3期373-378,共6页
调强放射治疗(IMRT)计划制定效率不高、难以保证治疗计划的高质量是目前调强放射治疗技术中一直存在的问题之一,基于形状的IMRT计划检索技术为缩短IMRT计划制定周期、提高放射治疗计划质量提供了一种新方法。本研究建立了一种适用于IMR... 调强放射治疗(IMRT)计划制定效率不高、难以保证治疗计划的高质量是目前调强放射治疗技术中一直存在的问题之一,基于形状的IMRT计划检索技术为缩短IMRT计划制定周期、提高放射治疗计划质量提供了一种新方法。本研究建立了一种适用于IMRT计划检索的重叠体积直方图(OVH)形状关系的关系描述算子,提出一种基于Matlab的计算方法。利用一例临床实际的鼻咽癌病例分析了OVH描述子的描述特性,利用22例临床鼻咽癌IMRT计划研究了其形状关系检索的性能。实验结果表明OVH描述子能够简洁的描述放疗三维场景中靶区和危及器官间的三维形状关系特征,并且能够有效检索出相似度较高的一组形状,适合于基于形状的IMRT计划检索。 展开更多
关键词 重叠体积直方图 形状关系描述算子 调强放射治疗 放疗计划优化
下载PDF
IMRT联合顺铂治疗宫颈癌的临床疗效及安全性研究 被引量:1
9
作者 张青冬 姜艳萍 +1 位作者 冯晓萍 汪萍萍 《中国性科学》 2018年第2期48-51,共4页
目的:研究IMRT联合顺铂治疗宫颈癌的临床疗效及安全性。方法:回顾性随机选择在2012年8月至2013年8月我院收治的136例宫颈癌患者,并按双盲数字法将其分为对照组和观察组。对照组患者采用单一的调强放射治疗(IMRT)治疗,观察组患者在调强... 目的:研究IMRT联合顺铂治疗宫颈癌的临床疗效及安全性。方法:回顾性随机选择在2012年8月至2013年8月我院收治的136例宫颈癌患者,并按双盲数字法将其分为对照组和观察组。对照组患者采用单一的调强放射治疗(IMRT)治疗,观察组患者在调强放射治疗(IMRT)治疗的基础上联合顺铂治疗。对患者进行定期回访3年,统计患者治疗3个月内复查结果为近期疗效及远期疗效。结果:通过对比,观察组治疗的有效率89.71%明显高于对照组治疗的有效率80.88%,差异具有统计学意义(P<0.05)。对比两组患者在治疗1年内,两组患者的生存率、局部控制率及无瘤生存率无明显差异,数据无统计学意义(P>0.05);但治疗1~3年内,观察组患者的生存率、远处转移率、局部控制率及无瘤生存率明显低于对照组,远处转移率明显低于对照组,差异对比有统计学意义(P<0.05)。观察组不良反应胃肠道反应、白细胞下降、放射性肠炎及骨髓抑制的发生率明显低于对照组,差异具有统计学意义(P<0.05)。结论:采用IMRT联合顺铂治疗宫颈癌患者的疗效优于采用单一的IMRT治疗的患者,并减少治疗后的不良反应,值得临床推广采纳。 展开更多
关键词 宫颈癌 顺铂 临床疗效 调强放射疗法
下载PDF
鼻咽鳞癌CNE1、CNE2细胞系IMRT模式离体照射生物效应研究 被引量:2
10
作者 王志 邬蒙 +2 位作者 何秀琴 王小平 陈文学 《实用癌症杂志》 2008年第3期248-251,共4页
目的观察适形调强放射治疗(IMRT)模式单次剂量输出时间延长对鼻咽鳞癌CNE1、CNE2细胞放射生物效应的影响,以便为临床制定个体化IMRT计划提供一些理论依据。方法分别急速照射指数生长期的CNE1细胞、CNE2细胞9个剂量点,采用克隆分析法计... 目的观察适形调强放射治疗(IMRT)模式单次剂量输出时间延长对鼻咽鳞癌CNE1、CNE2细胞放射生物效应的影响,以便为临床制定个体化IMRT计划提供一些理论依据。方法分别急速照射指数生长期的CNE1细胞、CNE2细胞9个剂量点,采用克隆分析法计算细胞存活分数,运用单靶多击和线性二次方程数学(LQ)模型拟合曲线,求出2种细胞放射生物学参数。将指数生长期的CNE-1细胞、CNE-2细胞分成3个组:①EBRT组;②IMRT模式15min照射组;③IMRT模式30min照射组(单次剂量输出时间延长至15min和30min)。每组照射总剂量为6Gy,1次/天,2Gy/次,连续照射3天,采用克隆分析法计算细胞的存活分数。结果急速照射1次后的各点细胞存活率以单靶多击模型拟合曲线,得出CNE1细胞D0值为0.88Gy,Dq值为0.47Gy,N值为3.5,CNE2细胞D0值0.60Gy,Dq值为0.36Gy,N值为4.0;以LQ模型拟合曲线,得出CNE1细胞α值为0.16Gy-1,β值为0.089Gy-2,α/β值为1.8Gy,CNE2细胞α值为0.97Gy-1,β值为0.086Gy-2,α/β值为11.3Gy。CNE1细胞EBRT组细胞存活率为7.21%,IMRT模式15min照射组为8.85%,IMRT模式30min照射组为9.92%,IMRT模式组随着单次剂量时间延长到15min和30min,细胞存活率较EBRT组明显增加,t检验有显著差异(P<0.05)。CNE2细胞EBRT组为0.190%,IMRT模式15min照射组为0.204%,IMRT模式30min照射组细胞存活率为0.207%,t检验无显著差异(P>0.05)。结论鼻咽高分化鳞癌CNE1细胞具有较低的α/β值及较大的D0、Dq值,相对于鼻咽低分化鳞癌CNE2细胞具有较强的亚致死性修复(SLDR)能力。SLDR能力在单次剂量延长的放疗中对细胞存活起重要作用。IMRT模式单次剂量输出时间延长将使CNE1细胞存活率增加明显,而CNE2细胞增加不明显。 展开更多
关键词 适形调强放疗 生物效应 细胞存活曲线 亚致死性损伤修复
下载PDF
适形调强放射治疗联合经动脉化疗栓塞治疗晚期肝细胞癌的预后研究
11
作者 王鸿飞 杨柳 +1 位作者 周解平 吴爱东 《中国医学装备》 2024年第4期13-17,共5页
目的:探讨适形调强放射治疗(IMRT)联合经动脉化疗栓塞(TACE)治疗晚期肝细胞癌(HCC)的疗效及预后。方法:回顾性分析2015年12月至2021年12月安徽省肿瘤医院收治的114例晚期HCC患者,所有患者均采用IMRT联合TACE治疗,使用单因素及多因素Cox... 目的:探讨适形调强放射治疗(IMRT)联合经动脉化疗栓塞(TACE)治疗晚期肝细胞癌(HCC)的疗效及预后。方法:回顾性分析2015年12月至2021年12月安徽省肿瘤医院收治的114例晚期HCC患者,所有患者均采用IMRT联合TACE治疗,使用单因素及多因素Cox生存分析确定影响患者生存期的独立预测影响因素。结果:经IMRT联合TACE治疗后所有患者的总有效率(完全缓解+部分缓解)为60.5%(69/114)。多因素分析发现肿瘤直径较大、高美国东部肿瘤协作组(ECOG)评分、Ⅲ~Ⅳ型门静脉癌栓(PVTT)、肝炎治疗和白细胞计数升高均是影响患者生存期的独立预测影响因素(HR=1.085、2.627、1.891、0.531、1.134,P<0.05)。结论:肿瘤Ⅲ~Ⅳ型PVTT和肿瘤直径较大对患者的生存有很大影响;而患者身体状态、肝炎治疗及全身炎症也是影响患者生存的重要因素。采用IMRT联合TACE治疗晚期HCC具有较好的治疗的效果,但应充分考虑预后生存影响因素。 展开更多
关键词 肝细胞癌(HCC) 癌栓 经动脉化疗栓塞(TACE) 三维适形调强放射治疗(3D-imrt)
下载PDF
Efficacy and safety of berberine in the prophylactic treatment of acute radiation proctitis in postoperative patients with cervical cancer:a randomized controlled study 被引量:3
12
作者 Kai Qin Yi Cheng +2 位作者 Xianglin Yuan Jing Zhang Le Huang 《Oncology and Translational Medicine》 CAS 2021年第1期1-6,共6页
Objective The aiom of this study was to study the efficacy and safety of berberine as a prophylactic treatment of acute radiation proctitis in postoperative patients with cervical cancer.Methods A total of 120 postope... Objective The aiom of this study was to study the efficacy and safety of berberine as a prophylactic treatment of acute radiation proctitis in postoperative patients with cervical cancer.Methods A total of 120 postoperative patients with cervical cancer were enrolled between July 2016 and October 2019,and randomly divided into a treatment group(berberine 300 mg three times a day,n=60)and a control group(receiving vitamin C tablets,100 mg three times a day;n=60)using the random number table method.All patients received pelvic intensity-modulated radiation therapy(IMRT)and concurrent sensitizing chemotherapy weekly.The difference in the percentage of irradiation volume to the rectum and small intestine as well as the incidence,onset time,severity,and duration of acute radiation proctitis and cystitis during radiotherapy were compared between the two groups.The completion rate,completion time,number of chemotherapy sessions,and quality of life during radiotherapy were also compared.Results There were no statistical differences in age,FIGO stage,pathological type,complications,highrisk factors,and rectum and small intestine irradiation dose distribution(V20,V30,V40,and V50)between the two groups(P>0.05).No acute radiation proctitis of grade 3 or above occurred in the two groups.There was no significant difference in the incidence of acute radiation cystitis,grade 2 acute radiation proctitis,completion rate of IMRT,and frequency of sensitization chemotherapy between the two groups.After prophylactic treatment with berberine,the incidence of grade 1 acute radiation proctitis,occurrence of grade 1 radiation proctitis,and completion time of radiotherapy in the treatment group were significantly lower than those in the control group(P<0.05).The SF-36 score of the treatment group after radiotherapy was 67.53±4.21,which was significantly better than that of the control group(64.90±6.32;P<0.05).The incidence of grade 3-4 neutropenia in the treatment group was 10%and lower than that in the control group(31.7%,P=0.003).No adverse reactions related to berberine were observed.Conclusion Prophylactic prescription with oral berberine can reduce the incidence,onset time,and duration of grade 1 acute radiation proctitis,and improve the quality of life of postoperative patients with cervical cancer receiving concurrent chemoradiotherapy. 展开更多
关键词 BERBERINE adjvuant therapy cervical cancer intensity-modulated radiation therapy(imrt) acute radiation proctitis
下载PDF
ExacTrac图像引导系统在鼻咽癌IMRT中的应用 被引量:5
13
作者 周军 李东春 +3 位作者 万久庆 罗灿 金俊余 李光辉 《临床肿瘤学杂志》 CAS 北大核心 2020年第4期334-338,共5页
目的探讨ExacTrac图像引导系统在鼻咽癌调强放射治疗(IMRT)摆位误差全程管控中的应用价值。方法收集2018年3月至2018年8月接受IMRT的30例鼻咽癌患者,采用ExacTrac图像引导系统全程实施图像引导放射治疗(IGRT),分析左右、头脚、腹背3个... 目的探讨ExacTrac图像引导系统在鼻咽癌调强放射治疗(IMRT)摆位误差全程管控中的应用价值。方法收集2018年3月至2018年8月接受IMRT的30例鼻咽癌患者,采用ExacTrac图像引导系统全程实施图像引导放射治疗(IGRT),分析左右、头脚、腹背3个平移方向及绕此3个方向旋转角度上的6D误差。结果ExacTrac图像引导系统校正前左右、头脚、腹背3个平移方向的误差值分别为(0.11±1.52)mm、(1.45±2.40)mm和(0.67±1.65)mm,绕此3个方向的旋转误差值分别为(-0.16±1.12)°、(0.32±1.59)°、(-0.38±1.12)°。校正后,左右、头脚、腹背3个平移方向的误差值分别为(-0.04±0.46)mm、(0±0.42)mm和(0.03±0.54)mm,绕此3个方向的旋转误差值分别为(-0.03±0.25)°、(0.01±0.23)°和(0.01±0.28)°。校正后在左右、头脚、腹背3个平移方向及绕此3个方向的旋转角度上,≤1 mm或1°的误差概率分别为99%、100%、99%、100%、100%和100%。2 mm或2°的误差概率在左右平移方向为1%,腹背平移方向为1%,其余方向为0。≥3 mm或3°的误差概率均为0。ExacTrac图像引导系统校正前后6D方向摆位误差的差异有统计学意义(P<0.05)。结论鼻咽癌患者在实施每分次IMRT的过程中行IGRT非常必要,应用ExacTrac图像引导系统可以明显校正摆位误差,提高放疗精准性。 展开更多
关键词 鼻咽癌 调强放射治疗(imrt) ExacTrac图像引导系统 图像引导放射治疗(IGRT) 摆位误差
下载PDF
SIB-IMRT与常规调强放射治疗食管癌的效果研究 被引量:4
14
作者 华传礼 王增才 《武警后勤学院学报(医学版)》 CAS 2021年第9期47-48,51,共3页
【目的】探讨同步整合加量调强放射治疗(SIB-IMRT)与常规调强放射治疗食管癌的效果。【方法】选取60例食管癌患者为研究对象,按随机数字表法将其分为实验组(n=19)和对照组(n=41),实验组予以SIB-IMRT治疗,对照组予以常规调强放射治疗。... 【目的】探讨同步整合加量调强放射治疗(SIB-IMRT)与常规调强放射治疗食管癌的效果。【方法】选取60例食管癌患者为研究对象,按随机数字表法将其分为实验组(n=19)和对照组(n=41),实验组予以SIB-IMRT治疗,对照组予以常规调强放射治疗。对比两组临床缓解情况、放射损伤情况、放射区域放射参数。【结果】治疗后,实验组总缓解率明显高于对照组(97.74%vs 63.41%)(P<0.05);实验组放射损伤情况总占比显著低于对照组放射损伤情况总占比(21.05%vs 51.22%)(P<0.05);实验组放射区域D95高于对照组,而放射区域V105及HI均低于对照组(P<0.05)。【结论】SIB-IMRT与常规调强放射治疗食管癌患者均有一定疗效,但前者的临床疗效明显优于后者,且毒副反应小,安全性较高,SIB-IMRT可作为治疗食管癌的优选放疗手段。 展开更多
关键词 SIB-imrt 常规调强放射治疗 食管癌 临床效果
下载PDF
The Reproducibility of Patient Setup for Head and Neck Cancers Treated with Image-Guided and Intensity-Modulated Radiation Therapies Using Thermoplastic Immobilization Device
15
作者 Akihiro Nakata Kunihiko Tateoka +5 位作者 Kazunori Fujimoto Yuichi Saito Takuya Nakazawa Tadanori Abe Masaki Yano Koichi Sakata 《International Journal of Medical Physics, Clinical Engineering and Radiation Oncology》 2013年第4期117-124,共8页
The reproducibility of patient setup is an important issue for head and neck cancers treated with intensity-modulated radiation therapy (IMRT). In this study, an image-guided radiation therapy (IGRT) system has been u... The reproducibility of patient setup is an important issue for head and neck cancers treated with intensity-modulated radiation therapy (IMRT). In this study, an image-guided radiation therapy (IGRT) system has been used to minimize the uncertainty of patient setup while standard thermoplastic masks were used to provide adequate immobilization for the head and neck. However, they do not provide sufficient immobilization of the shoulders, which is an important requirement in comprehensive nodal irradiation. Therefore, we investigated the setup and rotational shifts in head and neck cancer patients undergoing IMRT for which this immobilization device had been used together with an IGRT system. The setup and rotational shifts of patients were analyzed using the ExacTrac X-ray 6D IGRT system. The patients were classified as having head and neck tumors in the upper or lower regions. The upper neck nodes included lymph nodal level II while the lower neck nodes included lymph nodal levels III and IV. Clinical data from 227 treatment sessions of 12 head and neck cancer patients were analyzed. The random translational error in inter-and intra-fraction errors of the anterio-posterior (AP) direction might influence the rotational errors of pitch and roll in the upper region. At the same time, the random translational error in the inter-and intra-fraction errors of the AP direction might influence the rotational error of roll in the lower region. We believe that these random translational errors should be considered during treatment. We found variability in random translational errors for different regions in the anatomy of head and neck cancer patients due to rotational shifts. Depending on the location of the primary lesion or the selected nodal treatment targets, these relative positional variations should be considered when setup and rotational shifts are corrected with IGRT systems before treatment. 展开更多
关键词 imrt IGRT radiation therapy IMMOBILIZATION Head and Neck Cancer
下载PDF
The Dosimetric Effects of Different Beam Energy on Physical Dose Distributions in IMRT Based on Analysis of Physical Indices
16
作者 Ismail Eldesoky Ehab M. Attalla Wael M. Elshemey 《Journal of Cancer Therapy》 2013年第11期33-43,共11页
This work aimed at evaluating the effect of 6- and 10-MV photon energies on intensity-modulated radiation therapy (IMRT) treatment plan outcome in different selected diagnostic cases. For such purpose, 19 patients, wi... This work aimed at evaluating the effect of 6- and 10-MV photon energies on intensity-modulated radiation therapy (IMRT) treatment plan outcome in different selected diagnostic cases. For such purpose, 19 patients, with different types of non CNS solid tumers, were selected. Clinical step-and-shoot IMRT treatment plans were designed for delivery on a Siemens Oncor accelerator with 82 leafs;multi-leaf collimators (MLCs). To ensure that the similarity or difference among the plans is due to energy alone, the same optimization constraints were applied for both energy plans. All the parameters like beam angles, number of beams, were kept constant to achieve the same clinical objectives. The Comparative evaluation was based on dose-volumetric analysis of both energy IMRT plans. Both qualitative and quantitative methods were used. Several physical indices for Planning Target Volume (PTV), the relevant Organs at Risk (OARs) as mean dose (Dmean), maximum dose (Dmax), 95% dose (D95), integral dose, total number of segments, and the number of MU were applied. Homogeneity index and conformation number were two other evaluation parameters that were considered in this study. Collectively, the use of 6 MV photons was dosimetrically comparable with 10 MV photons in terms of target coverage, homogeneity, conformity, and OAR savings. While 10-MV plans showed a significant reduction in the number of MUs that varied between 4.2% and 16.6% (P-value = 0.0001) for the different cases compared to 6-MV. The percentage volumes of each patient receiving 2 Gy and 5 Gy were compared for the two energies. The general trend was that 6-MV plans had the highest percentage volume, (P-value = 0.0001, P-value = 0.006) respectively. 10-MV beams actually decreased the integral dose (from average 183.27 ± 152.38 Gy-Kg to 178.08 ± 147.71 Gy-Kg, P-value = 0.004) compared with 6-MV. In general, comparison of the above parameters showed statistically significant differences between 6-MV and 10-MV groups. Based on the present results, the 10-MV is the optimal energy for IMRT, regardless of the concerns about a potential risk of radiation-induced malignancies. It is recommended that the choice to treat at 10 MV be taken as a risk vs. benefit as the clinical significance remains to be determined on case by case basis. 展开更多
关键词 6- and 10-MV Photon ENERGIES INTENSITY-MODULATED radiation therapy (imrt) Dose-Volumetric ANALYSIS
下载PDF
全段食管癌调强放射治疗7野与8野对称式布野的效果研究
17
作者 戴翔 韩高华 +1 位作者 杨艳 吕圣兰 《生物医学工程与临床》 CAS 2023年第1期57-60,共4页
目的研究全段食管癌调强放射治疗计划设计中7野对称式布野与8野对称式布野的靶区及危及器官剂量学特点,为全段食管癌放射治疗患者的计划设计提供一定的参考。方法选择15例全段食管癌放射治疗患者,其中男性8例,女性7例;年龄45~84岁,平均... 目的研究全段食管癌调强放射治疗计划设计中7野对称式布野与8野对称式布野的靶区及危及器官剂量学特点,为全段食管癌放射治疗患者的计划设计提供一定的参考。方法选择15例全段食管癌放射治疗患者,其中男性8例,女性7例;年龄45~84岁,平均年龄62.5岁;病灶直径(2.8±1.3)cm;病灶长度(14.6±3.7)cm。采用Eclipse计划系统,全组处方剂量均为50 Gy,以95%靶区体积达到100%处方剂量为基准,剂量体积直方图(DVH)比较7野对称式布野与8野对称式布野计划设计方法的主要危及器官的受量。结果靶区均匀性指数(HI),7野对称式布野与8野对称式布野差异无统计学意义(0.55±0.01 vs 0.56±0.01。t=-2.092,P>0.05)。通过比较,全段食管癌调强放射治疗8野对称式布野肺部V_(20)、V_(5)低于7野对称式布野计划[(21.56±3.26)%vs(25.72±1.65)%、(59.60±6.02)%vs(60.48±6.40)%],其他器官差异无统计学意义。结论常规全段食管癌调强放射治疗计划中使用8野对称式布野计划设计方法可有效地减少肺部高剂量区体积,从而进一步减少放射性肺炎的发生率。 展开更多
关键词 食管癌 调强放射治疗 放射性肺炎 计划设计 对称式布野
下载PDF
调强放射治疗肺癌患者放射性肺炎发生的临床预测模型构建 被引量:4
18
作者 李娜 李丹 +6 位作者 谢辉 何丽煌 谢开红 徐敏仙 胡小毛 史巧静 李林 《中国医学装备》 2023年第6期23-28,共6页
目的:通过分析接受调强放射治疗(IMRT)的肺癌患者发生放射性肺炎(RP)的放射剂量学参数及临床病理特征,建立精确预测RP发生的临床模型。方法:选取医院收治的106例行IMRT的肺癌患者,依照临床表现及影像学检查结果将其分为RP组(44例)和非RP... 目的:通过分析接受调强放射治疗(IMRT)的肺癌患者发生放射性肺炎(RP)的放射剂量学参数及临床病理特征,建立精确预测RP发生的临床模型。方法:选取医院收治的106例行IMRT的肺癌患者,依照临床表现及影像学检查结果将其分为RP组(44例)和非RP组(62例),分析两组患者与RP相关的剂量学参数和临床病理等特征,并基于全肺总体积的15%、35%、40%(V_(15)、V_(35)、V_(40))、淋巴细胞计数、合并肺部感染、放射治疗剂量、总分期和T分期8个独立预后因素使用机器学习逻辑回归(LR)构建肺癌患者发生RP的临床预测模型(LR预测模型)。采用受试者工作特征(ROC)曲线分析LR预测模型在训练集和验证集中的预测效能。结果:106例患者中发生RP的44例(占41.5%),V_(15)、V_(35)、V_(40)、淋巴细胞计数、合并肺部感染、放射治疗剂量、总分期及T分期为发生RP的独立预后因素。训练集和验证集的ROC曲线下面积(AUC)分别为0.822和0.748,95%CI分别为0.714~0.931和0.488~0.979,模型的校正曲线(Brier score:0.171)和临床决策曲线表明该模型具有较好的预测性和临床有效性。结论:本研究构建的IMRT肺癌患者发生RP的临床LR预测模型,具有较好的预测性能和临床有效性,可为临床预测RP的发生及制定治疗策略提供依据。 展开更多
关键词 放射性肺炎(RP) 肺癌 放射治疗剂量 调强放射治疗(imrt) 临床预测模型
下载PDF
两种不同调强放射治疗中全脑放射治疗的海马和下丘脑-垂体轴剂量学比较研究 被引量:1
19
作者 李伶 李淑慧 +2 位作者 徐祖敏 梁玉新 周凌宏 《中国医学装备》 2023年第5期6-11,共6页
目的:比较3个非共面全弧容积旋转调强放射治疗(VMAT)与9野共面调强放射治疗(IMRT)在脑转移患者全脑照射保护海马和下丘脑-垂体轴计划中的剂量分布。方法:选取在医院进行放射治疗的12例肺癌脑转移患者图像资料。其中8例患者预防性颅脑照... 目的:比较3个非共面全弧容积旋转调强放射治疗(VMAT)与9野共面调强放射治疗(IMRT)在脑转移患者全脑照射保护海马和下丘脑-垂体轴计划中的剂量分布。方法:选取在医院进行放射治疗的12例肺癌脑转移患者图像资料。其中8例患者预防性颅脑照射(PCI)为36 Gy/18次,脑转移病灶推量(SIB)照射总剂量为54 Gy/18次;另4例患者只做了总剂量为36 Gy/18次的PCI治疗。每例患者分别设计3个非共面全弧VMAT(3A-VMAT)及9共面野IMRT(9F-IMRT)两种治疗计划,模拟设计海马和下丘脑-垂体(HT-P)轴区域的保留方法。放射治疗计划未实施到患者体内。评价两种计划适形性指数(CI)、均匀性指数(HI)、靶区覆盖(TC)、γ通过率、海马、下丘脑及垂体剂量。结果:(1)VMAT计划剂量SIB照射的CI、HI和TC分别为0.972、0.059和97.19%;IMRT计划剂量分别为0.955、0.083和95.45%,两种计划的HI比较差异有统计学意义(Z=3.524,P<0.05);(2)VMAT计划剂量全脑放射治疗(WBRT)的CI、HI和TC与IMRT计划比较,差异均有统计学意义(t=-5.007,t=-4.056,t=10.025;P<0.05);(3)VMAT计划左侧海马和右侧海马剂量最大辐射剂量(D_(max))、平均辐射剂量(D_(mean))和等效2 Gy剂量(EQD2)与IMRT计划比较,差异均有统计学意义(Z_(左侧海马)=-2.432,Z=-3.059,Z=2.432;Z_(右侧海马)=-3.059,Z=2.353,Z=-2.589;P<0.05);(4)VMAT计划HT-P D_(max)、HT-P D_(mean)和机器跳数(MU)值与IMRT计划比较,差异有统计学意义(Z=-3.059,Z=2.904,Z=-3.059;P<0.05)。VMAT计划与IMRT计划的γ通过率比较差异无统计学意义。结论:3个非共面全弧VMAT计划靶区剂量分布明显优于9野共面IMRT,对海马和下丘脑-垂体轴的保护VMAT也有较大优势。两种IMRT技术在全脑放射治疗同时保护海马和下丘脑-垂体轴均具有可行性,但需要进行前瞻性的神经系统、内分泌结果和安全性分析。 展开更多
关键词 全脑放射治疗(WBRT) 脑转移瘤 海马 调强放射治疗(imrt) 容积旋转调强放射治疗(VMAT)
下载PDF
体内剂量测量EPIgray系统的验收测试及临床应用评估
20
作者 蒋徐铭 贺晓东 +3 位作者 沈文同 陈佳艺 李敏 张毅斌 《中国医学装备》 2023年第12期26-32,共7页
目的:通过验收测试评估调强放射治疗(IMRT)及容积旋转调强治疗(VMAT)中在体剂量验证系统EPIgray剂量重建的准确度,并进行初步的临床应用。方法:选择医院收治的37例不同部位癌症患者病例进行临床测试,参考厂家提供的验收手册以及美国医... 目的:通过验收测试评估调强放射治疗(IMRT)及容积旋转调强治疗(VMAT)中在体剂量验证系统EPIgray剂量重建的准确度,并进行初步的临床应用。方法:选择医院收治的37例不同部位癌症患者病例进行临床测试,参考厂家提供的验收手册以及美国医学物理师协会(AAPM)TG-119报告的建议,采用方野、条带野和调强计划在模体上测试EPIgray系统的剂量重建精度。通过改变均匀模体厚度及照射源皮距来研究系统对误差的识别能力。对37例VMAT的不同部位癌症患者进行临床测试,分析EPIgray系统剂量重建与治疗计划系统计算剂量的一致性。结果:方野测试中EPIgray剂量重建有良好的线性且重建精度较高,在不同大小的射野不同厚度的模体上射野中心轴的剂量重建精度最高为(0.10±0.39)%,在离轴和深度方向上除剂量建成区和射野边缘外剂量重建精度均在3.0%以内。在IMRT以及VMAT计划测试中剂量重建偏差均<5.0%。随着计划复杂度以及模体异质性的增加重建精度略有下降,但剂量重建偏差均在允许偏差范围内。37例患者临床测试中处方剂量点的平均重建偏差为(-0.6±4.8)%,靶区范围内的采样点平均偏差为(-2.1±2.7)%。在射野外及剂量梯度大的区域重建偏差较大。结论:体剂量验证系统EPIgray剂量重建与治疗计划系统计算剂量有较好的一致性,剂量重建精度能满足临床应用的需求。 展开更多
关键词 调强放射治疗(imrt) 电子射野影像系统 容积旋转调强治疗(VMAT) 在体剂量学 质量保证
下载PDF
上一页 1 2 10 下一页 到第
使用帮助 返回顶部